A phase II study of ifosfamide and bleomycin in advanced or recurrent cervical carcinoma

International Journal of Gynecological Cancer

Volumn 6, Issue 4, 1996, Pages 323-327

  Highley, M S ^a,e   Samandas, N ^a   Ziras, N ^a   Morgan, M M ^b   Hill, M E ^a   Stein, R ^c   Barker, S ^a   Coleman, R E ^a   Blake, P R ^b   Morris, D ^a   Slevin, M L ^d   Wiltshaw, E ^b   Harper, P G ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^e NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

bleomycin; cervix neoplasms; ifosfamide

Indexed keywords

ANTIEMETIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; IFOSFAMIDE; MESNA; METHOTREXATE;

ADULT; AGED; ALOPECIA; ARTICLE; BLOOD TOXICITY; BRAIN DISEASE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; NAUSEA; NEPHROTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VOMITING;

EID: 8944256869     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1996.06040323.x     Document Type: Article

References (19)

1. Cancer Research Campaign. Cancer of the cervix uteri. Factsheet 1990; 12.1.
2. Meanwell CA, Mould JJ, Blackledge G, et al. Phase II study of ifosfamide in cervical cancer. Cancer Treat Rep 1986; 70: 727-30.
3. Coleman RE, Harper PG, Gallagher C, et al. A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix. Cancer Chemother Pharmacol 1986; 18: 280-3.
4. Hannigan EV, Dinh TV, Doherty MG. Ifosfamide with mesna in squamous carcinoma of the cervix: phase II results in patients with advanced or recurrent disease. Gynecol Oncol 1991; 43: 123-8.
5. Cervellino JC, Araujo CE, Pirisi C, Sanchez O, Brosto M, Rossi R. Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC study. Cancer Chemother Pharmacol 1990; 26 (Suppl.): S1-3.
6. Button GP, Blessing JA, Adcock L, Webster KD, DeEulis T. Phase II study of ifosfamide and mesna in patients with previously treated carcinoma of the cervix. A Gynecologic Oncology Group study. Invest New Drugs 1989; 7: 341-3.
7. Sutton GP, Blessing JA, McGuire WP, Patton T, Look KY. Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: A Gynecologic Oncology Group study. Am J Obstet Gynecol 1993; 168: 805-7.
8. Alberts DS, Garcia D, Mason-Liddil N. Cisplatin in advanced cancer of the cervix: an update. Seminars in Oncology 1991; 18 (Suppl. 3): 11-24.
9. Buxton EJ, Meanwell CA, Hilton C, et al. Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer. J Natl Cancer Inst 1989; 81: 359-61.
10. World Health Organisation. Handbook for reporting results of cancer treatment. WHO Offset Publication Geneva 1979; 48.
11. Coleman RE, Clarke JM, Slevin ML, et al. A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix. Cancer Chemother Pharmacol 1990; 27: 52-4.
12. Rose PG, Piver MS, Malfetano JH, Baker TR, Hempling RE, Recio FO. A phase II study of weekly cisplatin followed by cisplatin and ifosfamide in advanced or recurrent cervical carcinoma. Cancer 1993; 71: 2245-9.
13. Edmonson JH, Johnson PS, Wieand HS, et al. Phase II studies of bleomycin, cyclophosphamide, doxorubicin and cisplatin, and bleomycin and cisplatin in advanced cervical carcinoma. Am J Clin Oncol (CCT) 1988; 11 (Suppl. 2): 149-51.
14. Kumar L, Bhargava VL. Chemotherapy in recurrent and advanced cervical cancer. Gynecol Oncol 1991; 40: 107-11.
15. Ramm K, Vergote IB, Kaern J, Tropé CG. Bleomycin, ifosfamide, cis-platinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second look. Gynecol Oncol 1992; 46: 203-7.
16. Tay SK, Lai FM, Soh LT, Ho TH, Ang PT, Au E. Combined chemotherapy using cisplatin, ifosfamide and bleomycin (PIB) in the treatment of advanced and recurrent cervical carcinoma. Aust NZ J Obstet Gynaecol 1992; 32: 263-6.
17. Singhal RM, Jindel R, Gupta AK. Bleomycin, cisplatinum and ifosfamide infusion chemotherapy in advanced/recurrent cancer of cervix. Indian J Cancer 1993; 30: 158-63.
18. Zanetta G, Leventis C, Lo Monico S, Landoni F, Marzola M, Mangioni C. Bleomycin, ifosfamide and cis-platin chemotherapy in recurrent and persistent cervical cancer, a prospective study. Int J Gynecol Cancer 1995; 5: 56-60.
19. Manetta A. Bleomycin, ifosfamide and cisplatin (BIP) in patients with recurrent and advanced cervical cancer. Gynecol Oncol 1991; 42: 104-5.